Levocetirizine dihydrochloride
|
|
- Susan Williamson
- 6 years ago
- Views:
Transcription
1 INSERT TEXT UAP Levocetirizine dihydrochloride Allerzet 5 mg Tablet Antihistamine FORMULATION Each film-coated tablet contains: Levocetirizine dihydrochloride.. 5 mg PRODUCT DESCRIPTION Levocetirine 5 mg (Allerzet) is a white, round, biconvex, film-coated tablet that is plain on both sides. PHARMACODYNAMICS Levocetirizine is a selective H 1 antagonist that is an active R-enantiomer of cetirizine, a second generation antihistamine. Studies have shown that levocetirizine has twice the H 1 receptor affinity of cetirizine. Levocetirizine (at half of cetirizine dosage) appears to be as potent as cetirizine in inhibiting histamine-induced sneezing, nasal airway resistance and skin wheal and flare. Compared with other antihistamines (e.g., desloratadine, fexofenadine, loratadine), it exhibits greater and more consistent inhibition of histamine-induced wheal and flare; it has a more rapid onset and longer duration of action than other antihistamines. 1 of 6
2 PHARMACOKINETICS Levocetirizine is rapidly and extensively absorbed after oral administration. Peak plasma concentrations (C max ) (270 ng/ml and 308 ng/ml for single and repeated 5 mg doses, respectively) are seen at 0.9 hour following oral administration in adults. Levocetirizine can be taken with or without food. In vitro, mean plasma protein binding of levocetirizine is from 91 to 92%. The average apparent volume of distribution is approximately 0.4 L/kg. In humans, the extent of levocetirizine metabolism is less than 14% of the dose. Metabolic pathways include aromatic oxidation, N- and O-dealkylation and taurine conjugation. Levocetirizine is excreted mainly by the kidneys and the plasma half-life is about 8 to 9 hours following oral administration. Levocetirizine is excreted in the urine both by glomerular filtration and active tubular secretion. Mean oral total body clearance is approximately 0.63 ml/kg/min. Clearance of levocetirizine may not be significantly decreased in patients with solely hepatic impairment since levocetirizine is mainly excreted unchanged by the kidneys. Dosage adjustment is necessary for mild to severe renal impairment. INDICATIONS This medicine is used for: Allergic rhinitis: Symptomatic relief of seasonal (e.g., hay fever) and perennial allergic rhinitis Chronic idiopathic urticaria: Symptomatic treatment of uncomplicated skin manifestations DOSAGE AND ADMINISTRATION Adults and Children 12 years and older... Orally, 1 tablet once a day, at bedtime, Or, as recommended by a physician. Use in Elderly Dose should be carefully selected, usually starting at the lowest dose. 2 of 6
3 Hepatic and Renal Impairment No dosage adjustment is necessary for patients with solely hepatic impairment. For renal impairment in adults and children > 12 years old, proper dosage adjustment should be done according to the degree of renal impairment. Dosage for Symptomatic Treatment of Allergic Rhinitis and Chronic Idiopathic Urticaria in Adults and Children > 12 Years Old with Renal Impairment Degree of Renal Impairment Creatinine Clearance (ml/min) Oral Levocetirizine Dose Mild 50 to 79 1 tablet once a day Moderate 30 to 49 1 tablet once every 2 days Severe < 30 1 tablet once every 3 days End-Stage Renal Disease; Patients Undergoing Dialysis < 10 CONTRAINDICATED CONTRAINDICATIONS Hypersensitivity to levocetirizine, cetirizine, other piperazine derivatives, or any component of the product Adults and children > 12 years old with end-stage renal disease (creatinine clearance < 10 ml/min) or undergoing hemodialysis Pediatric patients 6 to 11 years of age with renal impairment Patients who are pregnant or breastfeeding WARNINGS AND PRECAUTIONS Somnolence, fatigue and asthenia are associated with levocetirizine treatment. Patients should exercise caution when performing hazardous activities requiring mental alertness and physical coordination (e.g., driving, operating machinery). Caution should be observed in epileptic patients and patients at risk of convulsions for possible increased risk of adverse effects. 3 of 6
4 INTERACTIONS WITH OTHER MEDICAMENTS CNS Depressants (e.g., Alcohol): Avoid concomitant use as a possible additive effect may be evident. Ritonavir: Ritonavir disposition is not altered but this may cause increased plasma AUC (42%), increased half-life (53%) and decreased clearance (29%) of cetirizine. Theophylline: Theophylline disposition is not altered but studies show that 400 mg theophylline decreased the clearance (~16%) of cetirizine. Higher doses may have a greater effect. Ketoconazole: Concomitant administration with cetirizine caused prolongation of QT C interval (increase of 17.4 msec). This was not considered clinically important. Azithromycin, Erythromycin, Cimetidine, Pseudoephedrine: No clinically important changes in ECG parameters and no pharmacokinetic interactions were observed with cetirizine. STATEMENT ON USAGE FOR HIGH RISK GROUPS Pregnancy: Pregnancy Category B. No adequate and well-controlled studies in pregnant women are available for levocetirizine. Levocetirizine should only be used during pregnancy when clearly needed. Lactation: The use of levocetirizine is not recommended in breastfeeding women as it is possibly distributed into milk (cetirizine is distributed into milk). Use in the elderly: Clinical experience with levocetirizine has not identified differences in responses between the elderly and younger patients. However, dose should be carefully selected for elderly patients, usually starting at the lowest dose due to greater frequency of decreased hepatic, renal or cardiac function and of concomitant disease or other drug therapy. Renal Impairment: Levocetirizine is mainly excreted by the kidneys and the risk of adverse effects may be greater in patients with impaired renal function. 4 of 6
5 UNDESIRABLE EFFECTS Common (above 1%) Adults and Children > 12 years old: Somnolence, headache, fatigue, dry mouth, nasopharyngitis, and pharyngitis Children 6 to 11 years old: Pyrexia, somnolence, cough, epistaxis, and rhinitis Uncommon (0.1 to 1%) to Very Rare (< 0.01%) General: Asthenia, malaise, edema, hypersensitivity, and anaphylactic shock Neurologic: Agitation, paresthesia, aggression, confusion, depression, hallucination, insomnia, convulsions, movement disorders, tic, dysgeusia, syncope, tremor, dystonia, and dyskinesia Dermatologic: Pruritus, rash, urticaria, angioneurotic edema, and fixed drug eruption Gastrointestinal: Abdominal pain and diarrhea Hepatobiliary: Increased transaminases, alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), and bilirubin Ophthalmic: Accomodation disorder, blurred vision and oculogyration Genitourinary: Dysuria and enuresis Others: Tachycardia, thrombocytopenia and increased weight OVERDOSE AND TREATMENT Symptoms of levocetirizine overdosage in adults may include drowsiness. In children, symptoms are initially agitation and restlessness, followed by drowsiness. No specific antidote is known and overdose is addressed by symptomatic or supportive treatment. Following short-term ingestion, gastric lavage may be considered. Dialysis may be ineffective unless a dialyzable agent was concomitantly ingested. STORAGE CONDITION Keep the product out of reach and sight of children Store at temperatures not exceeding 30 C 5 of 6
6 AVAILABILITY NAME / LOGO OF MANUFACTURER / IMPORTER / MARKETING AUTHORIZATION HOLDER CAUTION Foods, Drugs, Devices, and Cosmetics Act prohibits dispensing without prescription. DATE OF REVISION OF PACKAGE INSERT Note to UAP: Package insert revision date should be the date when the package insert is approved by Food and Drug Administration (FDA). 6 of 6
Cetirizine Proposed Core Safety Profile
Cetirizine Proposed Core Safety Profile Posology and method of administration Elderly subjects: data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Rinozal 5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 5 mg levocetirizine dihydrochloride
More informationComposition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:
Composition: Each tablet contain Montelukast Levocetirizine 10mg 5mg Each 5ml contains Montelukast Levocetirizine 4mg 2.5mg Pharmacokinetic properties: Peak plasma concentrations of montelukast are achieved
More informationMTnL Tablet/ MTnL Kid Tablet Montelukast & Levocetirizine dihydrochloride
MTnL Tablet/ MTnL Kid Tablet Montelukast & Levocetirizine dihydrochloride COMPOSITION MTnL Tablets Each film-coated tablet contains: Montelukast sodium equivalent to montelukast Levocetirizine dihydrochloride
More informationSUMMARY OF PRODUCT CHARACTERISTICS. One film-coated tablet contains 10 mg of cetirizine dihydrochloride.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cetirizin STADA 10 mg, film-coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 10 mg of cetirizine
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cetirizin Mylan 10 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 10 mg of cetirizine
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cetirizine 10 mg Film-Coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 10 mg cetirizine dihydrochloride.
More informationLevocetirizine dihydrochloride
Levocetirizine dihydrochloride Xyzal Oral Preparations PRODUCT DESCRIPTION Each film-coated tablet of Levocetirizine dihydrochloride (Xyzal ) contains 5 mg of levocetirizine. Each ml of Levocetirizine
More informationNEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg cetirizine hydrochloride.
NEW ZEALAND DATA SHEET 1. PRODUCT NAME Zista, 10 mg, tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg cetirizine hydrochloride. Excipient with known effect: lactose monohydrate
More informationNEW ZEALAND DATA SHEET. White, capsule shaped, film coated tablets marked CZ break line 10 on one side and G on the reverse.
NEW ZEALAND DATA SHEET RAZENE 1. Product Name Razene, 10 mg, film coated tablet. 2. Qualitative and Quantitative Composition Each film coated tablet contains 10 mg of cetirizine hydrochloride. Razene tablets
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cetec 10 mg film-coated tablets allacan TM 10mg film-coated tablets Health Essentials Hayfever and allergy Relief 10mg film-coated tablets
More informationCetirizine dihydrochloride
Cetirizine dihydrochloride Virlix Oral Preparations PRODUCT DESCRIPTION Cetirizine dihydrochloride (Virlix ) tablet: White oblong film coated tablet, with breakline and Y-Y logo, each containing 10mg Cetirizine
More informationPackage leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPage 1 of 9. Revised: 09/2012 FULL PRESCRIBING INFORMATION: CONTENTS *
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride)
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory LONGCET. Levocetirizine Dihydrochloride Tablets IP 5 mg
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory LONGCET Levocetirizine Dihydrochloride Tablets IP 5 mg QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One orodispersible
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cetirizine Hydrochloride 10 mg film-coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 10 mg of
More informationPackage leaflet: Information for the user Zirtek Allergy Relief 10 mg film-coated tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Zirtek Allergy Relief 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it
More informationPackage leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride
Package leaflet: Information for the patient Cetirizin Sandoz 10 mg film-coated tablets cetirizine dihydrochloride [For medicine available only on prescription:] Read all of this leaflet carefully before
More informationPackage Insert. Clistin Wet
Package Insert Clistin Wet Product Summary 1. Name of the medicinal product Clistin Wet 2. Qualitative and quantitative composition Levocetirizine Hydrochloride 2.5 mg Ambroxol Hydrochloride 30 mg Guaiphenesin
More informationSUMMARY OF PRODUCT CHARACTERISTICS
MUTUAL RECOGNITION PROCEDURE Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT, syrup 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of syrup contains 1 mg loratadine.
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory CETZINE / CETZINE SYRUP
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CETZINE / CETZINE SYRUP Cetirizine Tablets IP / Cetirizine Syrup IP QUALITATIVE AND QUANTITATIVE COMPOSITION CETZINE Tablet
More informationBody weight more than 30kg : 10ml (10mg) of the syrup once daily.
1. Name of the medicinal product Clarityn Allergy 1mg/ml Syrup 2. Qualitative and quantitative composition Each ml of syrup contains 1mg loratadine. Excipients with known effect. The quantity of sucrose
More informationPackage leaflet: Information for the user Zirtek Allergy Relief 10 mg Film Coated Tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Zirtek Allergy Relief 10 mg Film Coated Tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Fexofenadine Cipla 120 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 120 mg fexofenadine
More informationZyrtec Cetirizine dihydrochloride Film-coated tablets drops oral solution
Zyrtec Cetirizine dihydrochloride Film-coated tablets drops oral solution QUALITATIVE AND QUANTITATIVE COMPOSITION Zyrtec tablets are white oblong film-coated tablets, each containing 10 mg cetirizine
More informationPackage Leaflet: Information for the user. Anti-Hist Allergy 10mg Film-Coated Tablets. Cetirizine dihydrochloride
Package Leaflet: Information for the user Anti-Hist Allergy 10mg Film-Coated Tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Prolonged release tablet 5 mg cetirizine / 120 mg pseudoephedrine. Date of FAR:
Core Safety Profile Active substance: Cetirizine + Pseudoephedrine Pharmaceutical form(s)/strength: Prolonged release tablet 5 mg cetirizine / 120 mg pseudoephedrine P - RMS: BE/H/PSUR/0019/001 Date of
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fexofenadine hydrochloride 180 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 180mg
More informationPackage leaflet: Information for the user Zirtek Allergy Relief for Children 1 mg/ml Oral Solution Cetirizine dihydrochloride
Package leaflet: Information for the user Zirtek Allergy Relief for Children 1 mg/ml Oral Solution Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Telfast 120 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 120 mg of fexofenadine hydrochloride,
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Aciclovir Pharmaceutical form(s)/strength: Tablets 200, 400 or 800 mg Dispersible tablets 200, 400 or 800 mg Oral suspensions 200 mg or 400 mg per 5 ml. Freeze
More informationPackage leaflet: Information for the user. Cetirelief Allergy 10mg film-coated tablets. Cetirizine dihydrochloride
Package leaflet: Information for the user Cetirelief Allergy 10mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains
More informationFor the use only of Registered Medical Practitioners or a Hospital or a Laboratory CETZINE A
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CETZINE A Cetirizine Hydrochloride and Ambroxol Hydrochloride Tablets QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated
More informationAROMASIN 25mg (Tablets)
APPROVED PACKAGE INSERT AROMASIN SCHEDULING STATUS: S4 PROPRIETARY NAME AND DOSAGE FORM: AROMASIN 25mg (Tablets) COMPOSITION: Each sugar-coated tablet contains 25 mg exemestane. Preservative: methyl p-hydroxybenzoate
More informationPackage leaflet: Information for the user. Zynor Allergy 10 mg Film-coated Tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Zynor Allergy 10 mg Film-coated Tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the user. Zirtek 1 mg/ml oral solution. Cetirizine dihydrochloride
Package leaflet: Information for the user Zirtek 1 mg/ml oral solution Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More information(RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid hydrochloride.
Alzene Cetirizine hydrochloride PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Chemical name: cetirizine hydrochloride. (RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic
More informationMONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride )
Published on: 18 Dec 2015 MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ) Composition MONTAIR LC Tablets Each uncoated bilayered tablet contains: Montelukast
More informationLACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION
LACIPIL lacidipine QUALITATIVE AND QUANTITATIVE COMPOSITION Lacidipine, 2 mg - round shaped white engraved on one face. Lacidipine, 4 mg - oval white with break line on both faces. Lacidipine, 6 mg - oval
More informationPRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets
PRODUCT INFORMATION SUDAFED Sinus 12 Hour Relief Tablets NAME OF THE MEDICINE Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 DESCRIPTION SUDAFED Sinus 12 Hour Relief prolonged-release tablets
More informationC O N F I D E N T I A L
1. NAME OF THE MEDICINAL PRODUCT Lacinet 10 mg, orodispergeerbare tabletten Lacinet 20 mg, orodispergeerbare tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each orodispersible tablet contains 10
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT {To be completed nationally} 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 mg tablets: each tablet contains 1 mg granisetron (as hydrochloride).
More informationPACKAGE LEAFLET For medicinal products available on prescription
PACKAGE LEAFLET PACKAGE LEAFLET For medicinal products available on prescription Package leaflet: Information for the user Zirtek 1 mg/ml oral solution Cetirizine dihydrochloride Read all of this leaflet
More informationXYZAL 5 MG FILM-COATED TABLET
XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,
More informationPACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES
PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES Brand or Product Name [Product name] Suppositories mg Name and Strength of Active Substance(s) Eg Paracetamol 500mg Paracetamol 250mg Paracetamol 125mg
More informationPackage leaflet: Information for the user. Zirtek Allergy 1 mg/ml oral solution. Cetirizine dihydrochloride
Package leaflet: Information for the user Zirtek Allergy 1 mg/ml oral solution Cetirizine dihydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPACKAGE LEAFLET For medicinal products available on prescription
PACKAGE LEAFLET PACKAGE LEAFLET For medicinal products available on prescription Package leaflet: Information for the user Zirtek 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet
More informationVI.B.2 Elements for a public summary
VI.B.2 Elements for a public summary VI.B.2.1 Overview of disease epidemiology Fexofenadine hydrochloride is a non-sedating H 1 -antihistamine. [Fexofenadine] 180mg filmcoated tablets are indicated for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available
More informationNEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.
1. PRODUCT NAME ACUPAN 30 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nefopam hydrochloride 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM
More informationPARACOD Tablets (Paracetamol + Codeine phosphate)
Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationPRODUCT INFORMATION. Ammonium chloride is an expectorant that has an irritant effect on mucous membranes.
PRODUCT INFORMATION BENADRYL Original Oral Liquid (New Formula) Name of the Medicine Diphenhydramine hydrochloride Ammonium chloride The chemical name for diphenhydramine hydrochloride is 2-(diphenylmethoxy)-N,Ndimethylethanamine
More informationProduct Information. Zyrtec
Zyrtec PI Page 1 of 6 Australia NAME OF THE DRUG Cetirizine hydrochloride Product Information Zyrtec DESCRIPTION Cetirizine hydrochloride is an orally active, H 1 -receptor antagonist. Chemical name: 2-(2-(4-(4-chlorophenyl)
More informationEach 5ml of Sinarest LP New Syrup contains: Phenylephrine
Composition: Each 5ml of Sinarest LP New Syrup contains: Paracetamol Phenylephrine Levocetrizine 250mg 5mg 1.25mg Pharmacokinetic properties: Paracetamol is readily absorbed from the gastrointestinal tract
More informationCLINICAL PHARMACOLOGY
robaxin / robaxin -7 50 (methocarbamol tablets, USP) Rx Only DESCRIPT ION robaxin /robaxin -750 (methocarbamol tablets, USP), a carbamate derivative of guaifenesin, is a central nervous system (CNS) depressant
More informationSANDOMIGRAN (pizotifen malate)
SANDOMIGRAN (pizotifen malate) S N CH 3 Pizotifen. COOH CH OH CH 2 COOH MALATE DESCRIPTION Pizotifen is a cycloheptathiophene derivative structurally related to cyproheptadine and the tricyclic antidepressants.
More informationPRUCAPLA Tablets (Prucalopride)
Published on: 2 May 2018 PRUCAPLA Tablets (Prucalopride) Composition PRUCAPLA 1 mg Each film coated tablet contains: Prucalopride succinate equivalent to Prucalopride 1 mg Excipients. q. s. Color: Titanium
More informationNausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.
Nausicalm Cyclizine lactate 50 mg/ml solution for injection Presentation Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Uses Actions Cyclizine is a piperazine
More informationPackage leaflet: Information for the patient
Xyzal 5 mg/ml oral drops, solution Page 1 of 5 Package leaflet: Information for the patient Xyzal 5 mg/ml oral drops, solution For adults and children aged 2 years and above Levocetirizine dihydrochloride
More informationSILOFAST Capsules (Silodosin)
Published on: 10 Jul 2014 SILOFAST Capsules (Silodosin) Composition SILOFAST-4 Capsules Each hard gelatin capsule contains: Silodosin 4 mg Approved colours used in capsule shell SILOFAST-8 Capsules Each
More informationDOSAGE FORMS AND STRENGTHS CLARINEX Tablets - 5 mg (3) CLARINEX Oral Solution - 0.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CLARINEX safely and effectively. See full prescribing information for CLARINEX. CLARINEX (desloratadine)
More informationPackage leaflet: Information for the patient
Page 1 of 5 Package leaflet: Information for the patient Xyzal 5 mg/ml oral drops, solution For adults and children aged 2 years and above Levocetirizine dihydrochloride Read all of this leaflet carefully
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME Sudomyl, Tablet, 60 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substance Pseudoephedrine Hydrochloride 60mg Excipient(s) with known effect For the full
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Capsules, Tablets / 5 mg, 10 mg ES/H/PSUR/0013/001 Date of FAR:
Core Safety Profile Active substance: Flunarizine Pharmaceutical form(s)/strength: Capsules, Tablets / 5 mg, 10 mg P RMS: ES/H/PSUR/0013/001 Date of FAR: 13.12.2010 4.3 Contraindications Flunarizine is
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationTrust the Original to help you turn it off.
Trust the Original to help you turn it off. Trust the Original to help you turn it off. Trust the Original to help you turn it off. Trust the Original to help you turn it off. Trust the Original to help
More informationTranslated from Latvian Approved by SAM on
Translated from Latvian SAM on 29.07.2010 1. NAME OF THE MEDICINAL PRODUCT FENKAROL 10 mg Tablets FENKAROL 25 mg Tablets FENKAROL 50 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance
More informationFarmadol. Paracetamol 10 mg/ml INFUSION SOLUTION
Farmadol Paracetamol 10 mg/ml INFUSION SOLUTION Composition Each ml contains: Paracetamol 10 mg Pharmacology Pharmacodynamic properties The precise mechanism of the analgesic and antipyretic properties
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Aerius 5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg desloratadine. For a
More informationALFUSIN Tablets (Alfuzosin hydrochloride)
Published on: 20 Sep 2014 ALFUSIN Tablets (Alfuzosin hydrochloride) Composition Each film-coated extended-release tablet contains: Alfuzosin hydrochloride Ph.Eur... 10 mg Dosage Form Extended-release tablet
More informationEU RISK MANAGEMENT PLAN (EU-RMP)
EU RISK MANAGEMENT PLAN (EU-RMP) HYDROXYZINE 25 mg, scored film-coated tablets Active substance(s) (INN or common name): Hydroxyzine hydrochloride Pharmaco-therapeutic group (ATC Code): N05BB01, Anxiolytics
More informationData Sheet. BICALOX 50 mg is a white to off-white, round, film coated, biconvex tablets, engraved with 'BC 50' on one face and plain on the other.
BICALOX Data Sheet Bicalutamide 50 mg tablets Presentation BICALOX 50 mg is a white to off-white, round, film coated, biconvex tablets, engraved with 'BC 50' on one face and plain on the other. Uses Actions
More informationPackage leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine
Package leaflet: Information for the patient [To be completed nationally] 10 mg film-coated tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because it contains
More information* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.
Trade Name Aciloc 75 mg & 300 mg Film-coated tablets Generic Name Ranitidine Composition Each Aciloc 300 mg film-coated tablet contains: - Active ingredient: Ranitidine hydrochloride 336 mg equivalent
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 0.25 mg/ml, eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains 0.345 mg ketotifen fumarate corresponding
More information0BCore Safety Profile. Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) NL/H/PSUR/0058/001 Date of FAR:
0BCore Safety Profile Active substance: Omeprazole Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) P-RMS: NL/H/PSUR/0058/001 Date of FAR: 13.06.2013 4.2 Posology and method of administration
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Aerius 5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg desloratadine. Excipient(s)
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Immediate release tablets 1 mg, 2 mg, 4 mg and 8 mg (IR) Date of FAR:
Core Safety Profile Active substance: Doxazosin Pharmaceutical form(s)/strength: Immediate release tablets 1 mg, 2 mg, 4 mg and 8 mg (IR) P - RMS: DK/H/PSUR/0004/002 Date of FAR: 12.12.2011 4.3 Contraindications
More informationPackage Insert. Levasma Suspension. Product Summary. 1. Name of the medicinal product
Package Insert Levasma Suspension Product Summary 1. Name of the medicinal product Levasma suspension 2. Qualitative and quantitative composition Each 5 ml contains: Levocetirizine Dihydrochloride IP 2.5mg
More informationFURAMIST AZ Nasal Spray (Fluticasone furoate + Azelastine hydrochloride)
Published on: 27 Jan 2016 FURAMIST AZ Nasal Spray (Fluticasone furoate + Azelastine hydrochloride) Composition Each spray delivers: Azelastine Hydrochloride BP 140 mcg Fluticasone Furoate 27.5 mcg Dosage
More informationVESIGARD Tablets (Darifenacin hydrobromide)
Published on: 10 Jul 2014 VESIGARD Tablets (Darifenacin hydrobromide) Composition VESIGARD 7.5 Extended Release Tablets Each tablet contains: Darifenacin (as a hydrobromide).. 7.5 mg Dosage Form Tablets
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Aztreonam Pharmaceutical form(s)/strength: 500 mg, 1 g and 2 g powder for solution for injection and infusion NB! 75mg aztreonam for nebulisation to treat infections
More informationAnnex I: Proposed Core Safety Profile (CSP) 4.3 Contraindications
Annex I: Proposed Core Safety Profile (CSP) 4.3 Contraindications Hypersensitivity to cefuroxime or to any of the excipients listed in section 6.1. Patients with known hypersensitivity to cephalosporin
More informationbenzene acetic acid, 4-[1-hydroxy-4-[4-(hydroxy diphenylmethyl)-1- piperidinyl]butyl]-a,a-dimethyl-, hydrochloride
XERGIC Fexofenadine hydrochloride PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Chemical name: fexofenadine hydrochloride benzene acetic acid, 4-[1-hydroxy-4-[4-(hydroxy diphenylmethyl)-1-
More informationPackage leaflet: Information for the user. Hydroxyzine Bluefish 10 mg film-coated tablets hydroxyzine hydrochloride
Package leaflet: Information for the user Hydroxyzine Bluefish 10 mg film-coated tablets hydroxyzine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More informationLIVOSTIN Eye Drops and Nasal Spray
LIVOSTIN Eye Drops and Nasal Spray PRODUCT INFORMATION NAME OF DRUG Levocabastine hydrochloride DESCRIPTION Levocabastine, (-)-[3S-[1(cis), 3 alpha, 4 beta]]-1-[4-cyano-4-(4-fluorophenyl) cyclohexyl]-3-
More informationPharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml SI/H/PSUR/0002/002 Date of FAR:
0BCore Safety Profile Active substance: Ceftibuten Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml P-RMS: SI/H/PSUR/0002/002 Date of FAR: 14.02.2013
More informationPATIENT INFORMATION LEAFLET TEXAMER
SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,
More informationGranisetron Kabi, 1mg/ml, concentrate for solution for injection/infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Granisetron Kabi, 1mg/ml, concentrate for solution for injection/infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains granisetron
More informationSIFROL Composition Properties Indication
SIFROL Boehringer Composition 1 tablet contains: 0.125, 0.25 or 1.0 mg, (S)-2- amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole dihydrochloride monohydrate equivalent to 0.088, 0.18 or 0.7 mg pramipexole
More informationNEW ZEALAND DATA SHEET
NEW ZEALAND DATA SHEET VERGO 16 1. Product Name Vergo 16, 16 mg, tablet. 2. Qualitative and Quantitative Composition Each tablet contains 16 mg of betahistine dihydrochloride. For the full list of excipients,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 6 1. Name of the Medicinal Product Cycloserine 250mg Capsules 2. Qualitative and Quantitative Composition Each hard capsule contains: Cycloserine 250 mg For
More informationPRODUCT INFORMATION ZYRTEC LEVOCABASTINE Eye Drops and Nasal Spray
PRODUCT INFORMATION ZYRTEC LEVOCABASTINE Eye Drops and Nasal Spray NAME OF MEDICINE Levocabastine hydrochloride DESCRIPTION Levocabastine, (-)-[3S-[1(cis), 3 alpha, 4 beta]]-1-[4-cyano-4-(4-fluorophenyl)
More information